Sonoma Pharmaceuticals (SNOA) Current Leases (2017 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Current Leases came in at $151000.0 in Q1 2026, up 160.34% year-on-year from $58000.0 in Q1 2025, and up 3.42% quarter-over-quarter from $146000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Current Leases (2017 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Current Leases history runs 10 years deep, the most recent figure standing at $151000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 160.34% year-over-year to $151000.0 in Q1 2026; TTM through Mar 2026 was $151000.0, a 160.34% increase from a year earlier, with the FY2026 full-year figure at $151000.0, up 160.34% from the prior year.
- Current Leases climbed to $151000.0 in Q1 2026 per SNOA's latest filing, from $146000.0 in the prior quarter.
- Across five years, Current Leases topped out at $282000.0 in Q3 2022 and bottomed at $58000.0 in Q1 2025.
- The 5-year median for Current Leases is $181000.0 (2023), against an average of $177941.2.
- Across the five-year window, Current Leases tumbled 70.71% in 2025 and soared 160.34% in 2026, its largest moves.
- Year by year, Current Leases stood at $276000.0 in 2022, then plunged by 34.42% to $181000.0 in 2023, then plunged by 50.28% to $90000.0 in 2024, then soared by 62.22% to $146000.0 in 2025, then advanced by 3.42% to $151000.0 in 2026.
- Per Business Quant, the three latest SNOA Current Leases figures stand at $151000.0 (Q1 2026), $146000.0 (Q4 2025), and $88000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | 151,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 146,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 96,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 116,000.00 |
| Jun 30, 2024 | 155,000.00 |
| Mar 31, 2024 | 198,000.00 |
| Dec 31, 2023 | 181,000.00 |
| Sep 30, 2023 | 216,000.00 |
| Jun 30, 2023 | 233,000.00 |
| Mar 31, 2023 | 256,000.00 |
| Dec 31, 2022 | 276,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 250,000.00 |
| Dec 31, 2021 | 261,000.00 |
| Sep 30, 2021 | 276,000.00 |
| Jun 30, 2021 | 250,000.00 |